Cargando…

Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress

Blue light is reported to be harmful to eyes by inducing reactive oxygen species (ROS). Herein, the roles of Peucedanum japonicum Thunb. leaf extract (PJE) in corneal wound healing under blue light irradiation are investigated. Blue-light-irradiated human corneal epithelial cells (HCECs) show increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Wan Seok, Kim, Eun, Choi, Hakjoon, Lee, Ki Hoon, Kim, Kyeong Jo, Lim, Dosung, Choi, Su-young, Kim, Youngbae, Son, Seon ah, Kim, Jin Seok, Kim, Sunoh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295055/
https://www.ncbi.nlm.nih.gov/pubmed/37371901
http://dx.doi.org/10.3390/antiox12061171
_version_ 1785063329377550336
author Kang, Wan Seok
Kim, Eun
Choi, Hakjoon
Lee, Ki Hoon
Kim, Kyeong Jo
Lim, Dosung
Choi, Su-young
Kim, Youngbae
Son, Seon ah
Kim, Jin Seok
Kim, Sunoh
author_facet Kang, Wan Seok
Kim, Eun
Choi, Hakjoon
Lee, Ki Hoon
Kim, Kyeong Jo
Lim, Dosung
Choi, Su-young
Kim, Youngbae
Son, Seon ah
Kim, Jin Seok
Kim, Sunoh
author_sort Kang, Wan Seok
collection PubMed
description Blue light is reported to be harmful to eyes by inducing reactive oxygen species (ROS). Herein, the roles of Peucedanum japonicum Thunb. leaf extract (PJE) in corneal wound healing under blue light irradiation are investigated. Blue-light-irradiated human corneal epithelial cells (HCECs) show increased intracellular ROS levels and delayed wound healing without a change in survival, and these effects are reversed by PJE treatment. In acute toxicity tests, a single oral administration of PJE (5000 mg/kg) does not induce any signs of clinical toxicity or body weight changes for 15 days post-administration. Rats with OD (oculus dexter, right eye) corneal wounds are divided into seven treatment groups: NL (nonwounded OS (oculus sinister, left eye)), NR (wounded OD), BL (wounded OD + blue light (BL)), and PJE (BL + 25, 50, 100, 200 mg/kg). Blue-light-induced delayed wound healing is dose-dependently recovered by orally administering PJE once daily starting 5 days before wound generation. The reduced tear volume in both eyes in the BL group is also restored by PJE. Forty-eight hours after wound generation, the numbers of inflammatory and apoptotic cells and the expression levels of interleukin-6 (IL-6) largely increase in the BL group, but these values return to almost normal after PJE treatment. The key components of PJE, identified by high-performance liquid chromatography (HPLC) fractionation, are CA, neochlorogenic acid (NCA), and cryptochlorogenic acid (CCA). Each CA isomer effectively reverses the delayed wound healing and excessive ROS production, and their mixture synergistically enhances these effects. The expression of messenger RNAs (mRNAs) related to ROS, such as SOD1, CAT, GPX1, GSTM1, GSTP1, HO-1, and TRXR1, is significantly upregulated by PJE, its components, and the component mixture. Therefore, PJE protects against blue-light-induced delayed corneal wound healing via its antioxidative, anti-inflammatory, and antiapoptotic effects mechanistically related to ROS production.
format Online
Article
Text
id pubmed-10295055
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102950552023-06-28 Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress Kang, Wan Seok Kim, Eun Choi, Hakjoon Lee, Ki Hoon Kim, Kyeong Jo Lim, Dosung Choi, Su-young Kim, Youngbae Son, Seon ah Kim, Jin Seok Kim, Sunoh Antioxidants (Basel) Article Blue light is reported to be harmful to eyes by inducing reactive oxygen species (ROS). Herein, the roles of Peucedanum japonicum Thunb. leaf extract (PJE) in corneal wound healing under blue light irradiation are investigated. Blue-light-irradiated human corneal epithelial cells (HCECs) show increased intracellular ROS levels and delayed wound healing without a change in survival, and these effects are reversed by PJE treatment. In acute toxicity tests, a single oral administration of PJE (5000 mg/kg) does not induce any signs of clinical toxicity or body weight changes for 15 days post-administration. Rats with OD (oculus dexter, right eye) corneal wounds are divided into seven treatment groups: NL (nonwounded OS (oculus sinister, left eye)), NR (wounded OD), BL (wounded OD + blue light (BL)), and PJE (BL + 25, 50, 100, 200 mg/kg). Blue-light-induced delayed wound healing is dose-dependently recovered by orally administering PJE once daily starting 5 days before wound generation. The reduced tear volume in both eyes in the BL group is also restored by PJE. Forty-eight hours after wound generation, the numbers of inflammatory and apoptotic cells and the expression levels of interleukin-6 (IL-6) largely increase in the BL group, but these values return to almost normal after PJE treatment. The key components of PJE, identified by high-performance liquid chromatography (HPLC) fractionation, are CA, neochlorogenic acid (NCA), and cryptochlorogenic acid (CCA). Each CA isomer effectively reverses the delayed wound healing and excessive ROS production, and their mixture synergistically enhances these effects. The expression of messenger RNAs (mRNAs) related to ROS, such as SOD1, CAT, GPX1, GSTM1, GSTP1, HO-1, and TRXR1, is significantly upregulated by PJE, its components, and the component mixture. Therefore, PJE protects against blue-light-induced delayed corneal wound healing via its antioxidative, anti-inflammatory, and antiapoptotic effects mechanistically related to ROS production. MDPI 2023-05-29 /pmc/articles/PMC10295055/ /pubmed/37371901 http://dx.doi.org/10.3390/antiox12061171 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kang, Wan Seok
Kim, Eun
Choi, Hakjoon
Lee, Ki Hoon
Kim, Kyeong Jo
Lim, Dosung
Choi, Su-young
Kim, Youngbae
Son, Seon ah
Kim, Jin Seok
Kim, Sunoh
Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title_full Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title_fullStr Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title_full_unstemmed Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title_short Therapeutic Potential of Peucedanum japonicum Thunb. and Its Active Components in a Delayed Corneal Wound Healing Model Following Blue Light Irradiation-Induced Oxidative Stress
title_sort therapeutic potential of peucedanum japonicum thunb. and its active components in a delayed corneal wound healing model following blue light irradiation-induced oxidative stress
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295055/
https://www.ncbi.nlm.nih.gov/pubmed/37371901
http://dx.doi.org/10.3390/antiox12061171
work_keys_str_mv AT kangwanseok therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT kimeun therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT choihakjoon therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT leekihoon therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT kimkyeongjo therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT limdosung therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT choisuyoung therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT kimyoungbae therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT sonseonah therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT kimjinseok therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress
AT kimsunoh therapeuticpotentialofpeucedanumjaponicumthunbanditsactivecomponentsinadelayedcornealwoundhealingmodelfollowingbluelightirradiationinducedoxidativestress